123 related articles for article (PubMed ID: 5296412)
21. [Microbiological evaluation of a new synthetic cephalosporin, cephapirin (author's transl)].
Nakazawa S; Otsuki M; Kida K; Sakamichi T; Tanaka S
Jpn J Antibiot; 1974 Apr; 27(2):164-73. PubMed ID: 4152697
[No Abstract] [Full Text] [Related]
22. In vitro comparison of cefazolin with other cephalosporins.
Yeivin R; Meshulam M; Sacks T
Isr J Med Sci; 1974 Sep; 10(9):1092-5. PubMed ID: 4436031
[No Abstract] [Full Text] [Related]
23. Inactivation of cephalothin and cephaloridine by Staphylococcus aureus.
Benner EJ; Bennett JV; Brodie JL; Kirby WM
J Bacteriol; 1965 Dec; 90(6):1599-604. PubMed ID: 5175748
[TBL] [Abstract][Full Text] [Related]
24. [On the clinical aspects of cephalosporins. I. Bacteriological section].
Breitfellner G
Int Z Klin Pharmakol Ther Toxikol; 1969 Apr; 2(2):174-9. PubMed ID: 4895448
[No Abstract] [Full Text] [Related]
25. In vitro studies with Ciba 36278-Ba, a new cephalosporin derivative.
Russell AD
Microbios; 1972 Dec; 6(24):221-30. PubMed ID: 4487949
[No Abstract] [Full Text] [Related]
26. [Clinical application of cephaloridine and cephalothin].
Nakagawa K; Shoji F
J Antibiot B; 1965 Dec; 18(6):457-62. PubMed ID: 5329715
[No Abstract] [Full Text] [Related]
27. [Effectiveness of cephalosporins in experimental anaerobic gas infection].
Poliak MS
Antibiotiki; 1974 Aug; 19(8):733-6. PubMed ID: 4375943
[No Abstract] [Full Text] [Related]
28. Cephaloridine, laboratory and clinical evaluation.
Lane RA; Cox F; McHenry M; Quinn EL
Antimicrob Agents Chemother (Bethesda); 1966; 6():88-95. PubMed ID: 5985310
[No Abstract] [Full Text] [Related]
29. [Clinical study of cephalothin and cephaloridine in the field of dermatology].
Tanioku K; Arata J; Fujita S; Tokumaru N
J Antibiot B; 1965 Dec; 18(6):523-4. PubMed ID: 5296420
[No Abstract] [Full Text] [Related]
30. [Compared sensitivities to cephalothin cephaloridine cephalexin and ampicillin of 500 bacterial strains isolated in a hospital].
Courtieu AL; Sedallian A; Moinard D; Lecluse J
Pathol Biol (Paris); 1972 Jan; 20(1):43-50. PubMed ID: 4552029
[No Abstract] [Full Text] [Related]
31. In-vitro susceptibility of Mycobacterium fortuitum and related strains to cephalosporins.
Haas H; Michel J; Sacks TG
J Med Microbiol; 1973 May; 6(2):141-5. PubMed ID: 4488467
[No Abstract] [Full Text] [Related]
32. Comparative sensitivity of penicillinase producing Staphylococcus aureus to four cephalosporin antibiotics.
Bremner DA; Fortune J
N Z Med J; 1975 Sep; 82(548):189-90. PubMed ID: 1059959
[TBL] [Abstract][Full Text] [Related]
33. Growth inhibition of unusual strains of Staphylococcus aureus by lysostaphin and other antistaphylococcal antibiotics.
Zygmunt WA; Browder HP; Tavormina PA
Can J Microbiol; 1966 Apr; 12(2):341-5. PubMed ID: 5929159
[No Abstract] [Full Text] [Related]
34. Antimicrobial studies in vitro with cephacetrile, a new cephalosporin derivative.
Knüsel F; Konopka EA; Gelzer J; Rosselet A
Arzneimittelforschung; 1974 Sep; 24(9b):1451-5. PubMed ID: 4215433
[No Abstract] [Full Text] [Related]
35. Inhibition of amino acid transport in Escherichia coli by some beta-lactam antibiotics.
Anderson SV; Berg CM
Antimicrob Agents Chemother; 1977 Jun; 11(6):968-73. PubMed ID: 327925
[TBL] [Abstract][Full Text] [Related]
36. [Clinical study on a new synthetic cephalosporin (cephalothin) in surgical patients].
Naranjo Gómez A; de la Torre Carrasco F
Rev Clin Esp; 1975 Mar; 136(6):537-42. PubMed ID: 1094506
[No Abstract] [Full Text] [Related]
37. [Comparative experimental study of ceporin and oxacillin].
Zhukov VG; Navashin SM
Antibiotiki; 1970 Feb; 15(2):120-3. PubMed ID: 4910122
[No Abstract] [Full Text] [Related]
38. [Laboratory and clinical studies on cephalexin suspension (CEX-Susp.) in the pediatric field].
Kobayashi Y; Akaishi K; Nishio T; Imai C
Jpn J Antibiot; 1971 Feb; 24(1):8-26. PubMed ID: 5313286
[No Abstract] [Full Text] [Related]
39. Susceptibility of Enterobacter aerogenes and Enterobacter cloacae to 19 antimicrobial agents in vitro.
Toala P; Lee YH; Wilcox C; Finland M
Am J Med Sci; 1970 Jul; 260(1):41-55. PubMed ID: 4318051
[No Abstract] [Full Text] [Related]
40. [Validity of the measurement of sensitivity of Staphylococcus aureus with heterogeneous resistance to methicillin, oxacillin, cephalothin and cephaloridine].
Yourassowsky E; Schoutens E; Vanderlinden MP; Prudhomme MR; Van Audenarde M
Acta Clin Belg Suppl; 1971; 7():45-56. PubMed ID: 5292119
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
